研究業績 | Moi's Lab, Department of Medical Sciences, Graduate School of Medicine, the University of Tokyo

2021-Present

Nguyen TTN, Choo EM, Nakamura Y, Suzuki R, Shiina T, Shin-I T, Fukuta M, Nguyen CT, Nguyen TTT, Nguyen LKH, Hoang VMP, Morita K, Dang DA, Hasebe F, Le TQM, Moi ML. Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 and seasonal coronaviruses prior to the COVID-19 pandemic (2014-2019) with limited immunity against recent emerging SARS-CoV-2 variants, Vietnam. Int J Infect Dis. 2024 Feb;139:109-117.

Haga K, Chen ZN, Himeno M, Majima R, Moi ML. Utility of an In-Vitro Micro-Neutralizing Test in Comparison to a Plaque Reduction Neutralization Test for Dengue Virus, Japanese Encephalitis Virus, and Zika Virus Serology and Drug Screening. Pathogens. 2023 Dec 20;13(1):8.

Rahmasari R, Raekiansyah M, Aliyah SH, Yodi P, Baihaqy F, Irhamsyah M, Sari KCDP, Suryadi H, Moi ML, Sauriasari R. Development and validation of cost-effective SYBR Green-based RT-qPCR and its evaluation in a sample pooling strategy for detecting SARS-CoV-2 infection in the Indonesian setting. Sci Rep. 2024 Jan 20;14(1):1817.

Nguyen PHA, Fukushi S, Yamada S, Harada S, Yoshikawa T, Kinoshita H, Kawahara M, Ogawa T, Ebihara H, Moi ML, Saijo M. Analysis of antiviral drug properties of thymidine kinase of herpes B virus using recombinant herpes simplex virus 1. Microbiol Spectr. 2024 Jan 11;12(1):e0309123.

Balingit JC, Dimamay MPS, Suzuki R, Matsuda M, Xayavong D, Ngwe Tun MM, Matias RR, Natividad FF, Moi ML, Takamatsu Y, Culleton R, Buerano CC, Morita K. Role of pre-existing immunity in driving the dengue virus serotype 2 genotype shift in the Philippines: A retrospective analysis of serological data. Int J Infect Dis. 2024 Feb;139:59-68.

Abeygoonawardena H, Wijesinghe N, Navaratne V, Balasuriya A, Nguyen TTN, Moi ML, De Silva AD. Serological Evidence of Zika virus Circulation with Dengue and Chikungunya Infections in Sri Lanka from 2017. J Glob Infect Dis. 2023 Aug 30;15(3):113-120. doi: 10.4103/jgid.jgid_195_22.

Kobayashi D, Kai I, Faizah AN, Moi ML, Tajima S, Takasaki T, Sasaki T, Isawa H. Comparative analysis of the susceptibility of Aedes aegypti and Japanese Aedes albopictus to all dengue virus serotypes. Trop Med Health. 2023 Nov 2;51(1):61.

Taniguchi S, Maruyama J, Saito T, Littlefield K, Reyna RA, Manning JT, Huang C, Saijo M, Paessler S. Development of reverse genetics system for Guanarito virus: substitution of E1497K in the L protein of Guanarito virus S-26764 strain changes plaque phenotype and growth kinetics. J Virol. 2024 Feb 20;98(2):e0196423.

Fujii H, Fukushi S, Yoshikawa T, Nagata N, Taniguchi S, Shimojima M, Yamada S, Tani H, Uda A, Maeki T, Harada S, Kurosu T, Lim CK, Nakayama E, Takayama-Ito M, Watanabe S, Ebihara H, Morikawa S, Saijo M. Pathological and virological findings of type I interferon receptor knockout mice upon experimental infection with Heartland virus. Virus Res. 2024 Feb;340:199301.

Kasai M, Sakuma H, Abe Y, Kuki I, Maegaki Y, Murayama K, Murofushi Y, Nagase H, Nishiyama M, Okumura A, Sakai Y, Tada H, Mizuguchi M, Takanashi JI; Japanese Pediatric Neuro-COVID-19 Study Group. Clinical characteristics of SARS-CoV-2-associated encephalopathy in children: Nationwide epidemiological study. J Neurol Sci. 2024 Feb 15;457:122867.

Hoshino A, Takahashi N, Oka A, Mizuguchi M. Association of IL6 and IL10 gene promotor polymorphisms with susceptibility to acute necrotizing encephalopathy. Front Neurosci. 2023 Aug 3;17:1231957.

Shimoda K, Iwasaki H, Mizuno Y, Seki M, Mimaki M, Kato M, Shinozaki-Ushiku A, Mori H, Ogawa S, Mizuguchi M. Case Report: Tuberous sclerosis complex-associated hemihypertrophy successfully treated with mTOR inhibitor sirolimus. Front Pediatr. 2024 Feb 21;12:1333064.

Nakamura Y, Moi ML, Shiina T, Shin-I T, Suzuki R. Idiotope-Driven T-Cell/B-Cell Collaboration-Based T-Cell Epitope Prediction Using B-Cell Receptor Repertoire Sequences in Infectious Diseases. Viruses. 2023 May 17;15(5):1186. doi: 10.3390/v15051186.

Majima R, Edwards TC, Dreis CD, Geraghty RJ, Bonnac LF. Enhanced Remdesivir Analogues to Target SARS-CoV-2. Molecules. 2023 Mar 13;28(6):2616.

Phu Ly MH, Nguyen CT, Nguyen TV, Ngan Nguyen TT, Nabeshima T, Adungo F, Takamatsu Y, Huy NT, Mai Le TQ, Morita K, Hasebe F, Moi ML.Differential Infectivity of Human Neural Cell Lines by a Dengue Virus Serotype-3 Genotype-III with a Distinct Nonstructural Protein 2A (NS2A) Amino Acid Substitution Isolated from the Cerebrospinal Fluid of a Dengue Encephalitis Patient.　Can J Infect Dis Med Microbiol. 2023 Jan 17;2023:2635383.

Osawa T, Oya M, Okanishi T, Kuwatsuru R, Kawano H, Tomita Y, Niida Y, Nonomura N, Hatano T, Fujii Y, Mizuguchi M, Shinohara N.Clinical Practice Guidelines for tuberous sclerosis complex-associated renal angiomyolipoma by the Japanese Urological Association: Summary of the update. Int J Urol. 2023.

Sakuma H, Takanashi JI, Muramatsu K, Kondo H, Shiihara T, Suzuki M, Okanari K, Kasai M, Mitani O, Nakazawa T, Omata T, Shimoda K, Abe Y, Maegaki Y, Murayama K, Murofushi Y, Nagase H, Okumura A, Sakai Y, Tada H, Mizuguchi M. Severe pediatric acute encephalopathy syndromes related to SARS-CoV-2.; Japanese Pediatric Neuro-COVID-19 Study Group. Front Neurosci. 2023 Feb 27;17:1085082.

H, Kasai S, Sato A, Hagino Y, Nishito Y, Kobayashi T, Hino O, Mizuguchi M, Ikeda K. Tsc2 mutation rather than Tsc1 mutation dominantly causes a social deficit in a mouse model of tuberous sclerosis complex. Hum Genomics. 2023 Feb 2;17(1):4.

Murofushi Y, Sakuma H, Tada H, Mizuguchi M, Takanashi JI.Changes in the treatment of pediatric acute encephalopathy in Japan between 2015 and 2021: A national questionnaire-based survey. Brain Dev. 2023 Mar;45(3):153-160.

Mao ZQ, Minakawa N, Moi ML. Novel Antiviral Efficacy of Hedyotis diffusa and Artemisia capillaris Extracts against Dengue Virus, Japanese Encephalitis Virus, and Zika Virus Infection and Immunoregulatory Cytokine Signatures. Plants (Basel). 2022 Sep 30;11(19):2589. doi: 10.3390/plants11192589.

Himeno M, Chen SW, Kido T. Co-culture Model for Hepatitis B Virus Infection Using iPSC-Derived Liver Progenitor Cells and Liver Sinusoidal Endothelial Cells.. Methods Mol Biol.2022;2544:107-117.

Nwe KM, Ngwe Tun MM, Myat TW, Sheng Ng CF, Htun MM, Lin H, Hom NS, Soe AM, Elong Ngono A, Hamano S, Morita K, Thant KZ, Shresta S, Thu HM, Moi ML.. Acute-phase Serum Cytokine Levels and Correlation with Clinical Outcomes in Children and Adults with Primary and Secondary Dengue Virus Infection in Myanmar between 2017 and 2019. Pathogens, 2022 ; 10.3390/pathogens11050558

Raini SK, Takamatsu Y, Dumre SP, Urata S, Mizukami S, Moi ML, Hayasaka D, Inoue S, Morita K, Ngwe Tun MM.. Corrigendum to “The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection” [Antivir. Res. vol 192 (2021) 1-13/105121]. Antiviral Res, 2022 ; 10.1016/j.antiviral.2022.105245

Takemura T, Nguyen CT, Pham HC, Nguyen TT, Hoang VMP, Nguyen LKH, Nabeshima T, Nguyen TTT, Le TQM, Moi ML, Morita K, Hasebe F.. The 2017 Dengue virus 1 outbreak in northern Vietnam was caused by a locally circulating virus group. Trop Med Health, 2022 ; 10.1186/s41182-021-00386-0

Sasaki T, Moi ML, Saito K, Isawa H, Takasaki T, Sawabe K.. Aedes albopictus Strain and Dengue Virus Serotype in the Dengue Fever Outbreaks in Japan: Implications of Wolbachia Infection. Jpn J Infect Dis, 2022 ; 10.7883/yoken.JJID.2021.376

Satoh K, Takahashi K, Noguchi K, Kobayashi Y, Majima R, Iwase Y, Yamaguchi K, Masuda Y, Koshizuka T, Inoue N. Characterization of the Second Apoptosis Inhibitor Encoded by Guinea Pig Cytomegalovirus. J Virol. 2022 Dec 21;96(24):e0162222. He T, Edwards TC, Majima R, Jung E, Kankanala J, Xie J, Geraghty RJ, Wang Z. Repurposing N-hydroxy thienopyrimidine-2,4-diones (HtPD) as inhibitors of human cytomegalovirus pUL89 endonuclease: Synthesis and biological characterization. Bioorg Chem. 2022 Dec;129:106198.

Jung E, Soto-Acosta R, Xie J, Wilson DJ, Dreis CD, Majima R, Edwards TC, Geraghty RJ, Chen L. Bisubstrate Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 Nsp14 Methyltransferase. ACS Med Chem Lett. 2022 Jul 22;13(9):1477-1484. Jung E, Majima R, Edwards TC, Soto-Acosta R, Geraghty RJ, Wang Z. 8-Hydroxy-1,6-naphthyridine-7-carboxamides as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease. ChemMedChem. 2022 Sep 5;17(17):e202200334. d

Takahashi S, Takeguchi R, Tanaka R, Fukuoka M, Koike T, Ohtani H, Inoue K, Fukuda M, Kurahashi H, Nakamura K, Tominaga K, Matsubayashi T, Itoh M, Tanaka T. CDKL5 deficiency causes epileptic seizures independent of cellular mosaicism. J Neurol Sci. 2022 Dec 15;443:120498.

Moi ML.. [Dengue amidst COVID-19: challenges & control measures for the double burden]. Uirusu, 2021 ; 10.2222/jsv.71.1

Koui Y, Himeno M, Mori Y, Nakano Y, Saijou E, Tanimizu N, Kamiya Y, Anzai H, Maeda N, Wang L, Yamada T, Sakai Y, Nakato R, Miyajima A, Kido T.Development of human iPSC-derived quiescent hepatic stellate cell-like cells for drug discovery and in vitro disease modeling. Stem Cell Reports. 2021 Dec 14;16(12):3050-3063.

Shibata A, Kasai M, Hoshino A, Mizuguchi M. Association of IL-1B rs16944 Polymorphism With Acute Encephalopathy With Biphasic Seizures and Late Reduced Diffusion Is Opposite to That of Febrile Seizures. Front Neurol. 2022 May 30;13:891721.

Shibamura M, Yamada S, Yoshikawa T, Inagaki T, Nguyen PHA, Fujii H, Harada S, Fukushi S, Oka A, Mizuguchi M, Saijo M. Longitudinal Trends of Prevalence of Neutralizing Antibody against Human Cytomegalovirus over the Past 30 Years in Japanese Women. Jpn J Infect Dis. 2022 Sep 22;75(5):496-503.

Kasai M, Omae Y, Khor SS, Shibata A, Hoshino A, Mizuguchi M, Tokunaga K. Protective association of HLA-DPB1*04:01:01 with acute encephalopathy with biphasic seizures and late reduced diffusion identified by HLA imputation. Genes Immun. 2022 Jun;23(3-4):123-128.

Kasai M, Omae Y, Kawai Y, Shibata A, Hoshino A, Mizuguchi M, Tokunaga K. GWAS identifies candidate susceptibility loci and microRNA biomarkers for acute encephalopathy with biphasic seizures and late reduced diffusion. Sci Rep. 2022 Jan 25;12(1):1332.

Nguyen PHA, Yamada S, Harada S, Fukushi S, Mizuguchi M, Saijo M. Virulence of Herpes Simplex Virus 1 Harboring a UAG Stop Codon between the First and Second Initiation Codon in the Thymidine Kinase Gene. Jpn J Infect Dis. 2022 Jul 22;75(4):368-373

Mao ZQ, Fukuta M, Balingit JC, Nguyen TTN, Nguyen CT, Inoue S, Nguyen TTT, Nguyen LKH, Minakawa N, Morita K, Le TQM, Hasebe F, Moi ML.. Direct Viral RNA Detection of SARS-CoV-2 and DENV in Inactivated Samples by Real-Time RT-qPCR: Implications for Diagnosis in Resource Limited Settings with Flavivirus Co-Circulation. Pathogens, 2021 ; 10.3390/pathogens10121558

Azami NAM, Moi ML, Ami Y, Suzaki Y, Taniguchi S, Tajima S, Saijo M, Takasaki T, Kurane I, Lim CK.. Genotype-Dependent Immunogenicity of Dengue Virus Type 2 Asian I and Asian/American Genotypes in Common Marmoset (Callithrix jacchus): Discrepancy in Neutralizing and Infection-Enhancing Antibody Levels between Genotypes. Microorganisms, 2021 ; 10.3390/microorganisms9112196

2016-2020

Ng CFS, Seposo XT, Moi ML, Tajudin MABA, Madaniyazi L, Sahani M.. Characteristics of COVID-19 epidemic and control measures to curb transmission in Malaysia. Int J Infect Dis, 2020 ; 10.1016/j.ijid.2020.10.027

Buerano CC, Pangilinan LS, Dimamay MTA, Mapua CA, Dimamay MPS, Matias RR, Natividad FF, de Guzman Daroy ML, Hasebe F, Morita K, Moi ML.. Zika Virus Infection, Philippines, 2012. Emerg Infect Dis, 2020 ; 10.3201/eid2609.190896

Ngwe Tun MM, Moriuchi M, Toizumi M, Luvai E, Raini S, Kitamura N, Takegata M, Nguyen HT, Moi ML, Buerano CC, Anh DD, Yoshida LM, Morita K, Moriuchi H.. Congenital Zika Virus Infection in a Birth Cohort in Vietnam, 2017-2018. Am J Trop Med Hyg, 2020 ; 10.4269/ajtmh.20-0286

Azami NAM, Moi ML, Salleh SA, Neoh HM, Kamaruddin MA, Jalal NA, Ismail N, Takasaki T, Kurane I, Jamal R.. Dengue epidemic in Malaysia: urban versus rural comparison of dengue immunoglobulin G seroprevalence among Malaysian adults aged 35-74 years. Trans R Soc Trop Med Hyg, 2020 ; 10.1093/trstmh/traa056

Balingit JC, Phu Ly MH, Matsuda M, Suzuki R, Hasebe F, Morita K, Moi ML.. A Simple and High-Throughput ELISA-Based Neutralization Assay for the Determination of Anti-Flavivirus Neutralizing Antibodies. Vaccines (Basel), 2020 ; 10.3390/vaccines8020297

Nguyen CT, Moi ML, Le TQM, Nguyen TTT, Vu TBH, Nguyen HT, Pham TTH, Le THT, Nguyen LMH, Phu Ly MH, Ng CFS, Takemura T, Morita K, Hasebe F.. Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based survey. BMC Infect Dis, 2020 ; 10.1186/s12879-020-05042-2

Le TQM, Takemura T, Moi ML, Nabeshima T, Nguyen LKH, Hoang VMP, Ung THT, Le TT, Nguyen VS, Pham HQA, Duong TN, Nguyen HT, Ngu DN, Nguyen CK, Morita K, Hasebe F, Dang DA.. Severe Acute Respiratory Syndrome Coronavirus 2 Shedding by Travelers, Vietnam, 2020. Emerg Infect Dis, 2020 ; 10.3201/eid2607.200591

Muhammad Azami NA, Takasaki T, Kurane I, Moi ML.. Non-Human Primate Models of Dengue Virus Infection: A Comparison of Viremia Levels and Antibody Responses during Primary and Secondary Infection among Old World and New World Monkeys. Pathogens, 2020 ; 10.3390/pathogens9040247

Luz MAV, Nabeshima T, Moi ML, Dimamay MTA, Pangilinan LS, Dimamay MPS, Matias RR, Mapua CA, Buerano CC, de Guzman F, Tria ES, Natividad FF, Daroy MLG, Takemura T, Hasebe F, Morita K.. An Epidemic of Dengue Virus Serotype-4 during the 2015 – 2017: the Emergence of a Novel Genotype IIa of DENV-4 in the Philippines. Jpn J Infect Dis, 2020 ; 10.7883/yoken.JJID.2020.E001

Wijesooriya SL, Nguyen CT, Nguyen TTT, Vu TBH, Taichiro T, Morita K, Le TQM, Dang DA, Hasebe F, Moi ML.. Long-term surveillance needed to detect Zika virus outbreaks in endemic regions. Lancet Infect Dis, 2020 ; 10.1016/S1473-3099(19)30677-2

Bui TT, Moi ML, Morita K, Hasebe F.. Development of Universal and Lineage-Specific Primer Sets for Rapid Detection of the Zika Virus (ZIKV) in Blood and Urine Samples Using One-Step Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP). Jpn J Infect Dis, 2020 ; 10.7883/yoken.JJID.2019.073

Chen SW, Himeno M, Koui Y, Sugiyama M, Nishitsuji H, Mizokami M, Shimotohno K, Miyajima A, Kido T. Modulation of hepatitis B virus infection by epidermal growth factor secreted from liver sinusoidal endothelial cells. Sci Rep. 2020 Sep 1;10(1):14349.

Nguyen TTT, Tajima S, Ikeda M, Nguyen TT, Le TTH, Pham HTT, Pham DQ, Le MTQ, Maeki T, Taniguchi S, Kato F, Moi ML, Morita K, Lim CK, Saijo M, Hasebe F.. Neutralization Potency of Sera from Vietnamese Patients with Japanese Encephalitis (JE) against Genotypes I and V JE Viruses. Jpn J Infect Dis, 2019 ; 10.7883/yoken.JJID.2018.232

Bui TT, Moi ML, Nabeshima T, Takemura T, Nguyen TT, Nguyen LN, Pham HTT, Nguyen TTT, Manh DH, Dumre SP, Mizukami S, Hirayama K, Tajima S, Le MTQ, Aoyagi K, Hasebe F, Morita K.. A single amino acid substitution in the NS4B protein of Dengue virus confers enhanced virus growth and fitness in human cells in vitro through IFN-dependent host response. J Gen Virol, 2018 ; 10.1099/jgv.0.001092

Okuda K, Takao K, Watanabe A, Miyakawa T, Mizuguchi M, Tanaka T.. Comprehensive behavioral analysis of the Cdkl5 knockout mice revealed significant enhancement in anxiety- and fear-related behaviors and impairment in both acquisition and long-term retention of spatial reference memory. PLoS One, 2018 ; 10.1371/journal.pone.0196587

Azami NAM, Moi ML, Ami Y, Suzaki Y, Lim CK, Taniguchi S, Saijo M, Takasaki T, Kurane I.. Genotype-specific and cross-reactive neutralizing antibodies induced by dengue virus infection: detection of antibodies with different levels of neutralizing activities against homologous and heterologous genotypes of dengue virus type 2 in common marmose. Virol J, 2018 ; 10.1186/s12985-018-0967-x

Kobayashi D, Murota K, Fujita R, Itokawa K, Kotaki A, Moi ML, Ejiri H, Maekawa Y, Ogawa K, Tsuda Y, Sasaki T, Kobayashi M, Takasaki T, Isawa H, Sawabe K.. Dengue Virus Infection in Aedes albopictus during the 2014 Autochthonous Dengue Outbreak in Tokyo Metropolis, Japan. Am J Trop Med Hyg, 2018 ; 10.4269/ajtmh.17-0954

Ngwe Tun MM, Kyaw AK, Hmone SW, Inoue S, Buerano CC, Soe AM, Moi ML, Hayasaka D, Thu HM, Hasebe F, Thant KZ, Morita K.. Detection of Zika Virus Infection in Myanmar. Am J Trop Med Hyg, 2018 ; 10.4269/ajtmh.17-0708

Ly MHP, Moi ML, Vu TBH, Tun MMN, Saunders T, Nguyen CN, Nguyen AKT, Nguyen HM, Dao TH, Pham DQ, Nguyen TTT, Le TQM, Hasebe F, Morita K.. Dengue virus infection-enhancement activity in neutralizing antibodies of healthy adults before dengue season as determined by using FcγR-expressing cells. BMC Infect Dis, 2018 ; 10.1186/s12879-017-2894-7

Moi ML, Takasaki T, Kurane I.. Detection of Virus-Antibody Immune Complexes in Secondary Dengue Virus Infection. Methods Mol Biol, 2018 ; 10.1007/978-1-4939-6981-4_25

Moi ML, Ami Y, Muhammad Azami NA, Shirai K, Yoksan S, Suzaki Y, Kitaura K, Lim CK, Saijo M, Suzuki R, Takasaki T, Kurane I.. Marmosets (Callithrix jacchus) as a non-human primate model for evaluation of candidate dengue vaccines: induction and maintenance of specific protective immunity against challenges with clinical isolates. J Gen Virol, 2017 ; 10.1099/jgv.0.000913 Urakami A, Ngwe Tun MM, Moi ML, Sakurai A, Ishikawa M, Kuno S, Ueno R, Morita K, Akahata W.. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design. J Virol, 2017 ; 10.1128/JVI.01181-17

Moi ML, Nguyen TTT, Nguyen CT, Vu TBH, Tun MMN, Pham TD, Pham NT, Tran T, Morita K, Le TQM, Dang DA, Hasebe F.. Zika virus infection and microcephaly in Vietnam. Lancet Infect Dis, 2017 ; 10.1016/S1473-3099(17)30412-7

Okuda K, Kobayashi S, Fukaya M, Watanabe A, Murakami T, Hagiwara M, Sato T, Ueno H, Ogonuki N, Komano-Inoue S, Manabe H, Yamaguchi M, Ogura A, Asahara H, Sakagami H, Mizuguchi M, Manabe T, Tanaka T.. CDKL5 controls postsynaptic localization of GluN2B-containing NMDA receptors in the hippocampus and regulates seizure susceptibility. Neurobiol Dis, 2017 ; 10.1016/j.nbd.2017.07.002

Kyaw AK, Ngwe Tun MM, Moi ML, Nabeshima T, Soe KT, Thwe SM, Myint AA, Maung KTT, Aung W, Hayasaka D, Buerano CC, Thant KZ, Morita K.. Clinical, virological and epidemiological characterization of dengue outbreak in Myanmar, 2015. Epidemiol Infect, 2017 ; 10.1017/S0950268817000735

Yamanaka A, Moi ML, Takasaki T, Kurane I, Matsuda M, Suzuki R, Konishi E.. Utility of Japanese encephalitis virus subgenomic replicon-based single-round infectious particles as antigens in neutralization tests for Zika virus and three other flaviviruses. J Virol Methods, 2017 ; 10.1016/j.jviromet.2017.02.011

Yamanaka A, Moi ML, Takasaki T, Kurane I, Konishi E.. Neutralizing and enhancing antibody responses to five genotypes of dengue virus type 1 (DENV-1) in DENV-1 patients. J Gen Virol, 2017 ; 10.1099/jgv.0.000669

Ngwe Tun MM, V Muthugala R, Thi Thu Thuy N, Hoai Linh Ly P, Thi Hien Thu L, Thi Dinh D, Viet Hoang N, Thi Quynh Mai L, Moi ML, C Buerano C, Morita K, Hasebe F.. Dengue Associated Acute Encephalitis Syndrome Cases in Son La Province, Vietnam in 2014. Jpn J Infect Dis, 2017 ; 10.7883/yoken.JJID.2016.246

Tajima S, Nakayama E, Kotaki A, Moi ML, Ikeda M, Yagasaki K, Saito Y, Shibasaki KI, Saijo M, Takasaki T.. Whole Genome Sequencing-Based Molecular Epidemiologic Analysis of Autochthonous Dengue Virus Type 1 Strains Circulating in Japan in 2014. Jpn J Infect Dis, 2017 ; 10.7883/yoken.JJID.2016.086

Moi ML, Takasaki T.. [Dengue Fever]. Rinsho Byori, 2016 ; Moi ML, Kobayashi D, Isawa H, Sasaki T, Saijo M, Kurane I, Sawabe K, Takasaki T.. Dengue Virus Isolation in Mosquito Aedes albopictus Captured During an Outbreak in Tokyo, 2014, by a Method Relying on Antibody-Dependent Enhancement Mechanism Using FcγR-Expressing BHK Cells. Vector Borne Zoonotic Dis, 2016 ; 10.1089/vbz.2016.1982

Saito Y, Moi ML, Takeshita N, Lim CK, Shiba H, Hosono K, Saijo M, Kurane I, Takasaki T.. Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults. BMC Infect Dis, 2016 ; 10.1186/s12879-016-1873-8

Nakajima S, Watashi K, Ohashi H, Kamisuki S, Izaguirre-Carbonell J, Kwon AT, Suzuki H, Kataoka M, Tsukuda S, Okada M, Moi ML, Takeuchi T, Arita M, Suzuki R, Aizaki H, Kato T, Suzuki T, Hasegawa H, Takasaki T, Sugawara F, Wakita T.. Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System. J Virol, 2016 ; 10.1128/JVI.00856-16

Moi ML, Takasaki T, Kurane I.. Human antibody response to dengue virus: implications for dengue vaccine design. Trop Med Health, 2016 ; 10.1186/s41182-016-0004-y

Azami NA, Moi ML, Takasaki T.. Neutralization Assay for Chikungunya Virus Infection: Plaque Reduction Neutralization Test. Methods Mol Biol, 2016 ; 10.1007/978-1-4939-3618-2_25

Moi ML, Takasaki T.. Chikungunya Virus Growth and Fluorescent Labeling: Detection of Chikungunya Virus by Immunofluorescence Assay. Methods Mol Biol, 2016 ; 10.1007/978-1-4939-3618-2_13

Nakayama E, Kotaki A, Tajima S, Kawada M, Miura K, Gemma A, Adachi T, Sekizuka T, Kato K, Yamashita A, Moi ML, Ikeda M, Yagasaki K, Shibasaki K, Saijo M, Kuroda M, Takasaki T.. Two different dengue virus strains in the Japanese epidemics of 2014. Virus Genes, 2016 ; 10.1007/s11262-016-1356-4

Ngwe Tun MM, Kyaw AK, Makki N, Muthugala R, Nabeshima T, Inoue S, Hayasaka D, Moi ML, Buerano CC, Thwe SM, Thant KZ, Morita K.. Characterization of the 2013 dengue epidemic in Myanmar with dengue virus 1 as the dominant serotype. Infect Genet Evol, 2016 ; 10.1016/j.meegid.2016.04.025

Shinohara K, Kutsuna S, Takasaki T, Moi ML, Ikeda M, Kotaki A, Yamamoto K, Fujiya Y, Mawatari M, Takeshita N, Hayakawa K, Kanagawa S, Kato Y, Ohmagari N.. Zika fever imported from Thailand to Japan, and diagnosed by PCR in the urines. J Travel Med, 2016 ; 10.1093/jtm/tav011

2011-2015

Tajima S, Yagasaki K, Kotaki A, Tomikawa T, Nakayama E, Moi ML, Lim CK, Saijo M, Kurane I, Takasaki T.. In vitro growth, pathogenicity and serological characteristics of the Japanese encephalitis virus genotype V Muar strain. J Gen Virol, 2015 ; 10.1099/vir.0.000213

Okuda K, Tanaka T.. [Towards elucidating the regulatory roles of CDKL5 in synaptic transmission]. Nihon Yakurigaku Zasshi, 2015 ; 10.1254/fpj.145.183

Saito Y, Moi ML, Kotaki A, Ikeda M, Tajima S, Shiba H, Hosono K, Saijo M, Kurane I, Takasaki T.. Detecting Dengue Virus Nonstructural Protein 1 (NS1) in Urine Samples Using ELISA for the Diagnosis of Dengue Virus Infection. Jpn J Infect Dis, 2015 ; 10.7883/yoken.JJID.2014.441

Kutsuna S, Kato Y, Moi ML, Kotaki A, Ota M, Shinohara K, Kobayashi T, Yamamoto K, Fujiya Y, Mawatari M, Sato T, Kunimatsu J, Takeshita N, Hayakawa K, Kanagawa S, Takasaki T, Ohmagari N.. Autochthonous dengue fever, Tokyo, Japan, 2014. Emerg Infect Dis, 2015 ; 10.3201/eid2103/141662

Moi ML, Honma Y, Mori S, Kuze T, Kanekawa M, Isoda T, Moriwaki N, Hosogai T, Kotaki A, Kurane I, Saijo M, Miyake S, Takasaki T.. Virological confirmation of concurrent dengue virus serotypes 1 and 4 by virus isolation using Fc-gamma receptor-expressing BHK cells. Int J Infect Dis, 2015 ; 10.1016/j.ijid.2015.02.004

Ogawa R, Ma Y, Yamaguchi M, Ito T, Watanabe Y, Ohtani T, Murakami S, Uchida S, De Gaspari P, Uezumi A, Nakamura M, Miyagoe-Suzuki Y, Tsujikawa K, Hashimoto N, Braun T, Tanaka T, Takeda S, Yamamoto H, Fukada S.. Doublecortin marks a new population of transiently amplifying muscle progenitor cells and is required for myofiber maturation during skeletal muscle regeneration. Development, 2015 ; 10.1242/dev.122317

Moi ML, Ami Y, Shirai K, Lim CK, Suzaki Y, Saito Y, Kitaura K, Saijo M, Suzuki R, Kurane I, Takasaki T.. Formation of infectious dengue virus-antibody immune complex in vivo in marmosets (Callithrix jacchus) after passive transfer of anti-dengue virus monoclonal antibodies and infection with dengue virus. Am J Trop Med Hyg, 2015 ; 10.4269/ajtmh.14-0455

Tajima S, Kotaki A, Yagasaki K, Taniwaki T, Moi ML, Nakayama E, Saijo M, Kurane I, Takasaki T.. Identification and amplification of Japanese encephalitis virus and Getah virus propagated from a single porcine serum sample: a case of coinfection. Arch Virol, 2014 ; 10.1007/s00705-014-2152-x

Tochitani K, Shimizu T, Shinohara K, Tsuchido Y, Moi ML, Takasaki T.. [The first case report of Ross River virus disease in a Japanese patient who returned from Australia]. Kansenshogaku Zasshi, 2014 ; 10.11150/kansenshogakuzasshi.88.155

Kutsuna S, Kato Y, Takasaki T, Moi M, Kotaki A, Uemura H, Matono T, Fujiya Y, Mawatari M, Takeshita N, Hayakawa K, Kanagawa S, Ohmagari N.. Two cases of Zika fever imported from French Polynesia to Japan, December 2013 to January 2014 [corrected]. Euro Surveill, 2014 ; 10.2807/1560-7917.es2014.19.4.20683

Moi ML, Takasaki T, Omatsu T, Nakamura S, Katakai Y, Ami Y, Suzaki Y, Saijo M, Akari H, Kurane I.. Demonstration of marmosets (Callithrix jacchus) as a non-human primate model for secondary dengue virus infection: high levels of viraemia and serotype cross-reactive antibody responses consistent with secondary infection of humans. J Gen Virol, 2014 ; 10.1099/vir.0.060384-0

Moi ML, Takasaki T, Saijo M, Kurane I.. Determination of antibody concentration as the main parameter in a dengue virus antibody-dependent enhancement assay using FcγR-expressing BHK cells. Arch Virol, 2014 ; 10.1007/s00705-013-1787-3

Moi ML, Omatsu T, Hirayama T, Nakamura S, Katakai Y, Yoshida T, Saito A, Tajima S, Ito M, Takasaki T, Akari H, Kurane I.. Presence of Viral Genome in Urine and Development of Hematuria and Pathological Changes in Kidneys in Common Marmoset (Callithrix jacchus) after Inoculation with Dengue Virus. Pathogens, 2013 ; 10.3390/pathogens2020357

Sakakibara A, Ando R, Sapir T, Tanaka T.. Microtubule dynamics in neuronal morphogenesis. Open Biol, 2013 ; 10.1098/rsob.130061 Moi ML, Omatsu T, Tajima S, Lim CK, Kotaki A, Ikeda M, Harada F, Ito M, Saijo M, Kurane I, Takasaki T.. Detection of dengue virus nonstructural protein 1 (NS1) by using ELISA as a useful laboratory diagnostic method for dengue virus infection of international travelers. J Travel Med, 2013 ; 10.1111/jtm.12018

Moi ML, Takasaki T, Kurane I.. Efficacy of tetravalent dengue vaccine in Thai schoolchildren. Lancet, 2013 ; 10.1016/S0140-6736(13)60754-0

Shin E, Kashiwagi Y, Kuriu T, Iwasaki H, Tanaka T, Koizumi H, Gleeson JG, Okabe S.. Doublecortin-like kinase enhances dendritic remodelling and negatively regulates synapse maturation. Nat Commun, 2013 ; 10.1038/ncomms2443

Moi ML, Takasaki T, Saijo M, Kurane I.. Dengue virus infection-enhancing activity of undiluted sera obtained from patients with secondary dengue virus infection. Trans R Soc Trop Med Hyg, 2013 ; 10.1093/trstmh/trs007

Ujiie M, Moi ML, Kato Y, Takasaki T.. Response to letter. J Travel Med, 2013 ; 10.1111/j.1708-8305.2012.00664_2.x

Ujiie M, Moi ML, Kobayashi T, Takeshita N, Kato Y, Takasaki T, Kanagawa S.. Dengue virus type-3 infection in a traveler returning from Benin to Japan. J Travel Med, 2012 ; 10.1111/j.1708-8305.2012.00617.x

Omatsu T, Moi ML, Takasaki T, Nakamura S, Katakai Y, Tajima S, Ito M, Yoshida T, Saito A, Akari H, Kurane I.. Changes in hematological and serum biochemical parameters in common marmosets (Callithrix jacchus) after inoculation with dengue virus. J Med Primatol, 2012 ; 10.1111/j.1600-0684.2012.00552.x

Moi ML, Lim CK, Chua KB, Takasaki T, Kurane I.. Dengue virus infection-enhancing activity in serum samples with neutralizing activity as determined by using FcγR-expressing cells. PLoS Negl Trop Dis, 2012 ; 10.1371/journal.pntd.0001536

Ujiie M, Moi ML, Takeda N.. Dengue maculopathy in a traveler. Am J Trop Med Hyg, 2011 ; 10.4269/ajtmh.2011.11-0120

Moi ML, Lim CK, Tajima S, Kotaki A, Saijo M, Takasaki T, Kurane I.. Dengue virus isolation relying on antibody-dependent enhancement mechanism using FcγR-expressing BHK cells and a monoclonal antibody with infection-enhancing capacity. J Clin Virol, 2011 ; 10.1016/j.jcv.2011.07.009

Omatsu T, Moi ML, Hirayama T, Takasaki T, Nakamura S, Tajima S, Ito M, Yoshida T, Saito A, Katakai Y, Akari H, Kurane I.. Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity. J Gen Virol, 2011 ; 10.1099/vir.0.031229-0

Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I.. Detection of higher levels of dengue viremia using FcγR-expressing BHK-21 cells than FcγR-negative cells in secondary infection but not in primary infection. J Infect Dis, 2011 ; 10.1093/infdis/jir053

Before 2010